Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.41 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28683368 | 1.00 | KDM4E (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL28745103 | 0.92 | DGKA (0.54) | DGKAFFAR1FFAR4 | |
| SCHEMBL738730 | 0.89 | USP2 (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL20917644 | 0.89 | USP2 (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL29151843 | 0.89 | USP2 (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL14778639 | 0.89 | USP2 (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL170853 | 0.89 | KDM4E (0.58) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL1173137 | 0.89 | USP2 (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL28797571 | 0.89 | USP2 (0.47) | KDM4EDUSP3MEN1KMT2ALMNA | |
| SCHEMBL28349445 | 0.89 | USP2 (0.47) | KDM4EDUSP3MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111107841-B | Method for preparing solid dosage forms comprising antibodies by wet granulation, extrusion and spheronization | 蒂洛特斯制药股份有限公司 | 2023-03-10 | — | — | CN | disclosed |